Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

14.76
Delayed Data
As of Mar 24
 -0.04 / -0.27%
Today’s Change
10.43
Today|||52-Week Range
45.20
-2.19%
Year-to-Date
Can The Uptrend Continue for Intra-Cellular Therapies (ITCI)?
Mar 17 / Zacks.com - Paid Partner Content
5 Cheap Breakout Stocks for Superb Returns
Mar 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close14.80
Today’s open14.89
Day’s range14.49 - 14.93
Volume217,033
Average volume (3 months)577,359
Market cap$640.7M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)-19.70%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book1.70

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.35+2.48%
AMPHAmphastar Pharmaceut...+0.05+0.36%
CTMXCytomX Therapeutics ...+0.37+2.12%
ARDXArdelyx Inc-0.10-0.75%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts


Search for Jobs